UTILITY OF VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL IN PREDICTION OF BIO-NAIVE CROHN'S DISEASE PATIENTS OUTCOMES TREATED WITH ADALIMUMAB OR USTEKINUMAB

Vedran Tomasic  ¹     Alen Biscanin  ^{1, 2}     Petra Cacic  ²     Leon Palac  ²     Zdravko Dorosulic  ²     Dominik Kralj  ²     Filip Babic  ²     Doris Ogresta  ²     Davor Hrabar  ^{1, 2    
1} University Hospital Center Sestre Milosrdnice, Zagreb, Croatia
² University of Zagreb, School of Medicine, Zagreb, Croatia

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)